MedPath

宜昌三峡制药有限公司

Ownership
-
Established
1999-07-20
Employees
-
Market Cap
-
Website
http://www.sanxiapharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

77

NMPA:77

Drug Approvals

Neomycin Sulfate

Product Name
硫酸新霉素
Approval Number
国药准字H42022147
Approval Date
Oct 10, 2024
NMPA

Compound Sodium Lactate and Glucose Injection

Product Name
复方乳酸钠葡萄糖注射液
Approval Number
国药准字H20033480
Approval Date
Jan 11, 2023
NMPA

Glycerol and Sodium Chloride Injection

Product Name
甘油氯化钠注射液
Approval Number
国药准字H20033502
Approval Date
Nov 16, 2022
NMPA

Dextran 40 Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H42021688
Approval Date
Nov 16, 2022
NMPA

Zedoray Turmeric Oil and Glucose Injection

Product Name
莪术油葡萄糖注射液
Approval Number
国药准字H20033695
Approval Date
Nov 16, 2022
NMPA

Sorbitol Injection

Product Name
山梨醇注射液
Approval Number
国药准字H42021684
Approval Date
Nov 16, 2022
NMPA

Metronidazole and Glucose Injection

Product Name
甲硝唑葡萄糖注射液
Approval Number
国药准字H42021676
Approval Date
Nov 16, 2022
NMPA

Polyglucose and Sodium Chloride Injection

Product Name
缩合葡萄糖氯化钠注射液
Approval Number
国药准字H42021685
Approval Date
Nov 16, 2022
NMPA

Sodium Glucuronic Acid and Sodium Chloride Injection

Product Name
葡醛酸钠氯化钠注射液
Approval Number
国药准字H20051817
Approval Date
Nov 16, 2022
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H42022153
Approval Date
Oct 18, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.